Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Research Highlights
Nature Reviews Cancer 8, 572–573 (1 August 2008) | doi:10.1038/nrc2450
Angiogenesis: Turning it down a Notch
Abstract
The resistance of several tumour types to vascular endothelial growth factor (VEGF) inhibition has prompted the hunt for alternative molecular targets in the angiogenic cascade. A recent study confirms the NOTCH1 receptor as one such target.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
